Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
NCT07729137
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Diseases
Menlo Park, California, United States
View Trial DetailsNCT Number: NCT03685734
To assess objective and subjective visual outcomes achieved by patients with corneal endothelial dysfunction who have undergone surgical treatment with Descemet stripping automated endothelial keratoplasty (DSAEK).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Since 2006, the technique by removing the Descemet membrane from the recipient cornea was renamed Descemet stripping automated endothelial keratoplasty (DSAEK). In recent years, DSAEK techniques have evolved, favoring increasingly thinner and finer grafts, known as ultrathin DSAEK (UT DSAEK), with the aim of obtaining better visual results.
Endothelial keratoplasty is now the most common surgical procedure used to treat endothelial dysfunction. The current study focused on assessing both objective and subjective visual quality outcomes following DSAEK.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Scored with reference to the logarithm of the minimum angle of resolution (logMAR) and its variation in line gain.
Centre Hospitalier Régional Metz-Thionville
Other
Visual Outcomes Following Descemet Stripping Automated Endothelial Keratoplasty for Corneal Endothelial Dysfunction
Acronym: VO-DSAEK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729137
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Diseases
Menlo Park, California, United States
View Trial DetailsNCT05436665
Bullous Keratopathy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Edegem, Antwerp, Belgium
View Trial Details